In a news release, the company says the job cuts of about 8,500 are part of "a global initiative to sharpen its commercial and research and development (R&D) focus."
Merck, based in Whitehouse Station, N.J., expects to save about $2.5 billion in annual net costs by the end of 2015. It expects to realize $1 billion of those savings by the end of 2014.
For Merck, it's job cuts on top of job cuts. The 8,500 jobs to be eliminated are in addition to the 7,500 positions Merck already has announced, the company said in its news release.
"These actions will make Merck a more competitive company, better positioned to drive innovation and to more effectively commercialize medicines and vaccines for the people who need them," said Kenneth C. Frazier, chairman and chief executive officer, in a statement. "Today's announcement further underscores that we are committed to improving our performance in the short term while also investing for the long term to create value for patients, customers and shareholders."
Top 5 High Dividend Companies To Buy Right Now: Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals, Inc. (Supernus), incorporated on March 30, 2005, is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Supernus is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder (ADHD). Supernus�� two epilepsy product candidates are SPN-538 and Epliga. Epliga is in Phase III clinical trials. Supernus ADHD product candidates include SPN-810 (molindone hydrochloride), a treatment for impulsive aggression in patients with ADHD, and SPN-812, a non-stimulant treatment for ADHD. Both of these programs are in Phase II. In addition to these four products candidates, Supernus has several additional product candidates in various stages of development, including SPN-809. Its wholly owned subsidiary includes TCD Royalty Sub LLC.
Supernus�� Late-Stage Neurology Portfolio
SPN-538 is an oral once-daily extended release topiramate product for the treatment of epilepsy. Topiramate is marketed by Johnson & Johnson under the brand name Topamax and is available in a generic form. As of December 31, 2009, Topiramate was available only in immediate release form and is indicated for monotherapy and adjunctive therapy of epilepsy and for the treatment of migraine. It works by enhancing the inhibitory effect of the Gamma-Aminobutyric Acid (GABA) neurotransmitter that regulates neuronal excitability throughout the nervous system, blocking the excitatory effect of the glutamate neurotransmitter, blocking the sodium channel and inhibiting the carbonic anhydrase enzyme.
Epliga is an oral once-daily extended release formulation of oxcarbazepine. As of December 31, 2009, Epliga was in Phase III trials. Oxcarbazepine is marketed by Novartis under the brand name Trileptal and is available in a generic form. Trileptal is indicated for monotherap! y and adjunctive therapy of epilepsy. Oxcarbazepine is an active voltage-dependent sodium channel blocker.
Supernus�� Psychiatry Portfolio
SPN-810 (molindone hydrochloride) is a treatment for impulsive aggression in patients with ADHD. As of December 31, 2009, it was in Phase II. SPN-810 is based on molindone hydrochloride. As of December 31, 2009, the Company had completed four clinical trials for SPN-810, including a Phase IIa trial, in which it tested the safety and tolerability of immediate release molindone hydrochloride in children with ADHD who suffer from serious persistent conduct problems. This open-label, dose-ranging trial randomized 78 children, 6-12 years of age, into one of four treatment groups, which were given four different doses of immediate release molindone hydrochloride, between 10 milligram and 40 milligram per day, depending on weight, three times a day over a six-week treatment period, after 2-5 weeks of titration. SPN-810 was well tolerated in the trial with no clinically meaningful changes in standard hematology, clinical chemistry values, vital signs or electrocardiogram results. SPN-810 also showed improvements on the primary and secondary outcome measures, such as conduct problem and ADHD scales, across all four treatment groups. SPN-812 is a non-stimulant treatment for ADHD. As of December 31, 2009, SPN-812 was in Phase II. SPN-812 is a selective norepinephrine reuptake inhibitor.
Supernus�� Technology Platforms
The Company has a long track record of developing products by applying technologies to known drugs to improve existing therapies and to enable the treatment of new indications. Supernus�� main technology platforms include: Microtrol (multiparticulate delivery platform), Solutrol (matrix delivery platform) and EnSoTrol (osmotic delivery system). The Company�� technologies have been used in the approved and marketed products, including Carbatrol (carbamazepine), Equetro (carbamazepine), Adderall XR (mixe! d ampheta! mine salts), Sanctura XR (trospium chloride), Oracea (doxycycline) and Intuniv (guanfacine).
Advisors' Opinion:- [By Sara Sjolin]
Shares of Supernus Pharmaceuticals (SUPN) �could also be active, after the company jumped 20% after-hours on Monday after a drug on which the firm collaborated received Food and Drug Administration approval.
- [By Monica Gerson]
Supernus Pharmaceuticals (NASDAQ: SUPN) confirmed the FDA approval of its partner's heart blood-pressure treatment. Supernus shares jumped 18.24% to $8.75 in after-hours trading.
- [By Wallace Witkowski]
Shares of Supernus Pharmaceuticals (SUPN) �jumped 20% after hours Monday after a drug on which the firm collaborated received Food and Drug Administration approval.
- [By Monica Gerson]
Supernus Pharmaceuticals (NASDAQ: SUPN) is expected to post a Q4 loss at $0.55 per share on revenue of $7.78 million.
Geron (NASDAQ: GERN) is projected to post a Q4 loss at $0.07 per share on revenue of $350.00 thousand.
10 Best Long Term Stocks To Buy For 2014: Capital One Financial Corporation(COF)
Capital One Financial Corporation operates as the bank holding company for the Capital One Bank (USA), National Association (COBNA), and Capital One, National Association (CONA), which provide various financial products and services in the United States, the United Kingdom, and Canada. It offers consumer and small business credit card lending, national closed end installment lending, and the international credit card lending services. The company also provides various non-interest bearing and interest-bearing deposits, including demand deposits, money market deposits, negotiable order of withdrawal accounts, savings accounts, certificates of deposit, and other consumer time deposits. Its loan portfolio comprises credit card loans; consumer loans, such as auto, home, and retail banking loans; and commercial loans, including commercial and multifamily real estate, middle market, specialty lending, and small-ticket commercial real estate loans. In addition, the company provid es mortgage banking, treasury management, and depository services. It primarily serves consumers, small businesses, and commercial clients through branches, the Internet, and other distribution channels. The company was founded in 1993 and is headquartered in McLean, Virginia.
Advisors' Opinion:- [By Rich Smith]
In fact, Citi has already made moves in this direction, picking up Best Buy's (NYSE: BBY ) branded credit card business from Capital One (NYSE: COF ) earlier this year. Granted, this move seems to contradict Citi's old strategy of lightening up on credit cards, as demonstrated when it unloaded a $1.6 billion credit card portfolio on General Electric (NYSE: GE ) back in 2010. But that was then, this is now, and today, DTAs are the issue that needs fixing.
- [By Lee Jackson]
Capital One Financial Corp. (NYSE: COF) has become famous for its hilarious commercials featuring actor Alec Baldwin. The bank also is slowly but surely becoming one of the top credit card companies. The stock ranks as one of the top holdings in billionaire Andreas Halvorsen’s Viking Global hedge fund, which now owns 15 million shares. Oppenheimer has a $78 price target on the stock. The Thomson/First Call price target is $75. Investors are paid a 1.8% dividend.
- [By Dan Caplinger]
The big potential for Schwab lies in going after 401(k) accounts. Currently, mutual funds dominate 401(k) plan investment options, but ETFs are making inroads into the multitrillion-dollar industry. Despite existing competition from TD AMERITRADE and Capital One's (NYSE: COF ) ShareBuilder -- and with Fidelity's recent expansion of its ETF partnership with BlackRock's (NYSE: BLK ) iShares unit signaling another potential entrant to the space -- Schwab's plans to launch an all-ETF 401(k) plan next year could tap a larger part of a lucrative market.
10 Best Long Term Stocks To Buy For 2014: Xcel Energy Inc.(XEL)
Xcel Energy Inc., through its subsidiaries, engages in the generation, purchase, transmission, distribution, and sale of electricity to residential, commercial, and industrial customers, as well as to public authorities in the United States. The company generates electricity using coal, nuclear, natural gas, hydro, wood, diesel, and wind energy. It also engages in the purchase, transportation, distribution, and sale of natural gas to residential, commercial, and industrial customers. The company serves customers in portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. As of December 31, 2010, it provided electricity services to 3,391,611 customers; and natural gas services to 1,893,250 customers. Xcel Energy, through its joint venture interests in WYCO Development LLC, develops and leases natural gas pipeline, storage, and compression facilities. The company was founded in 1909 and is based in Minneapolis, Minnesota.
Advisors' Opinion:- [By David Dittman]
Xcel Energy Inc�� (NYSE: XEL) coal-fired generation was 42.3 percent of its total 2013output. Xcel was down 0.2 percent.
NRG Energy Inc�� (NYSE: NRG) 2013 coal-fired share of generation was 28.8 percent, but it�� been actively adding renewable sources. Its stock was up 2.2 percent. NextEra Energy Inc (NYSE: NEE), owner/operator of the largest fleet of renewable generation in the US with just 1.7 percent of its output from coal, was up 2.8 percent.
10 Best Long Term Stocks To Buy For 2014: Hydrogenics Corp (HYGS)
Hydrogenics Corporation, incorporated on June 10, 2009, together with its subsidiaries, designs, develops and provides hydrogen generation and fuel cell products based on water electrolysis technology and proton exchange membrane (PEM) technology. The Company conducts its business through two business units: OnSite Generation, which focuses on hydrogen generation products for renewable energy, industrial and transportation customers, and Power Systems, which focuses on fuel cell products for original equipment manufacturers (OEMs) systems integrators and end users for stationary applications, including backup power, and motive applications, such as forklift trucks. The Company�� products include HySTAT hydrogen generation equipment in its OnSite Generation business and HyPM fuel cell products in its Power Systems business.
The Company maintains operations in Belgium, Canada and Germany. Its OnSite Generation business segment is based in Oevel, Belgium and develops products for industrial gas, hydrogen fueling and renewable energy storage markets. The Company�� Power Systems business segment is based in Mississauga, Canada, with a satellite facility in Gladbeck, Germany, and develops products for energy storage, stationary and motive power applications.
OnSite Generation
The Company�� OnSite Generation business segment, is based on water electrolysis technology, which includes the decomposition of water into oxygen (O2) and hydrogen gas (H2) by passing an electric current through a liquid electrolyte. Its brand includes HySTAT electrolyzer products, which is configured for both indoor and outdoor applications. Its OnSite Generation products are sold to merchant gas companies, such as Air Liquide and Linde Gas and end-users requiring hydrogen produced on-site for industrial applications. The Company also sells and services products for oil and gas companies, such as Shell Hydrogen, requiring hydrogen fueling stations for transportation applications.
Power Systems
The Company�� Power Systems business segment is based on PEM fuel cell technology, which transforms chemical energy liberated during the electrochemical reaction of hydrogen and oxygen into electrical energy. It also develops and delivers hydrogen generation products based on PEM water electrolysis, which can also be used to serve the energy storage markets. Its target markets include backup power for telecom and data centre installations and motive power applications, such as buses, trucks and utility vehicles. The Company�� Power Systems products are sold to original equipment manufacturers (OEMs), such as CommScope, Inc. (CommScope) to provide backup power applications for telecom installations and vehicle and other integrators for motive power, direct current (DC) and alternative current (AC) backup. In addition, its products are sold for prototype field tests. The Company also sells its Power Systems products to the military.
HySTAT Hydrogen Stations
HySTAT Hydrogen Stations offer an on-site supply of hydrogen for a range of hydrogen applications, including vehicle fuelling, distributed power, and a variety of industrial processes. It also provides spare parts and service for its entire installed base.
As of December 31, 2011, the Company offered its HySTAT Hydrogen Station in multiple configurations based on the amount of hydrogen required. This product is suitable for producing continuous or batch supplies of hydrogen for industrial processing applications and generates between 10 - 60 normal cubic meters per hour (Nm3/hr) of hydrogen.
HyPM Fuel Cell Products
The Company�� HyPM fuel cell products provide electrical power from clean hydrogen fuel. Its HyPM fuel cell products include HyPM Fuel Cell Power Modules, HyPX Fuel Cell Power Pack, Integrated Fuel Cell Systems and Engineering Development Services. Its HyPM power module runs on hydrogen and produces direct current (DC) power. This product! is suita! ble for a range of stationary, mobile and portable power applications. The HyPM XR model is targeted at backup power applications and the HyPMHD model is targeted at motive power applications. The Company�� HyPX Power Pack includes a HyPM power module integrated with hydrogen storage tanks and ultracapacitors that provide higher power in short bursts. Its integrated fuel cell systems are built around its HyPM power modules and used for portable and stationary applications, including portable and auxiliary power units for military applications and DC backup power system for cellular tower sites. The Company also enters into engineering development contracts with certain customers for new or custom products.
The Company competes with Air Liquide and Linde Gas.
Advisors' Opinion:- [By Paul Ausick]
Peers Plug Power Inc. (NASDAQ: PLUG), Ballard Power Systems Inc. (NASDAQ: BLDP), and Hydrogenics Corp. (NASDAQ: HYGS) have also shared in the stock price run-up. Any investor expecting more from FuelCell�� results was, perhaps, being irrationally exuberant.
10 Best Long Term Stocks To Buy For 2014: China Auto Logistics Inc.(CALI)
China Auto Logistics Inc. primarily engages in the sale and trading of imported automobiles in the People?s Republic of China. It also offers financing services, including letter of credit issuance, purchase deposit financing, and import duty advances, as well as automobile value-added services, including customs clearance, storage, and nationwide delivery services to automobile dealers and agents. In addition, the company operates Websites that provide subscribers with sales and trading information for imported and domestically manufactured automobiles. Its Websites include cali.com.cn, which provides auto living public with information about auto and auto-related products and services; at188.com that provides sales and trading information about imported automobiles, as well as parts and components information; at160.com, which provides sales and trading information about domestically manufactured automobiles; and goodcar.cn that provides information relating to automoti ve products and services, including discounted gas, car washes, emergency roadside assistance, body-shop repairs, and car maintenance. The company sells automobiles to authorized dealers, free traders or wholesalers, government agencies, and individual customers. China Auto Logistics Inc. is based in Tianjin, the People?s Republic of China.
Advisors' Opinion:- [By Monica Gerson]
China Auto Logistic (NASDAQ: CALI) shares dropped 9.06% to $3.17 after the company announced 2013 results. China Auto Logistic posted its net income of $524,260, or $0.14 per share.
10 Best Long Term Stocks To Buy For 2014: Baxter International Inc. (BAX)
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pha rmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.
Advisors' Opinion:- [By Monica Gerson]
Baxter International (NYSE: BAX) is expected to report its Q3 earnings at $1.19 per share on revenue of $3.81 billion.
Dover (NYSE: DOV) is projected to report its Q3 earnings at $1.50 per share on revenue of $2.31 billion.
10 Best Long Term Stocks To Buy For 2014: DealerTrack Holdings Inc.(TRAK)
DealerTrack Holdings, Inc. provides software solutions to the automotive retail industry in the United States and Canada. The company offers DealerTrack DMS, an open platform to integrate and manage functions of store operations. It also provides sales and finance solutions, including DealerTrack Credit Application Network to transmit a consumer?s credit application information to lenders; BookOut to look up used automobile values; DealerTrack Compliance to sign, store, and protect customer and financing activity; DealerTrack eContracting to obtain electronic signatures, and transmit contracts and contract information electronically to lenders; DealTransfer to transfer transaction information; CreditOnline to submit credit application data online; SalesMaker, a desking system; DealerTrack eMenu to present insurance and other aftermarket product options in a menu format; and DealerTrack Aftermarket Network that offers real-time aftermarket contract rating and quote generat ion. In addition, the company provides inventory solutions, such as DealerTrack eCarList, an inventory management and distribution platform; and DealerTrack AAX, an inventory optimization and analytics system. Further, it offers processing solutions, such as DealerTrack OLRS that provides do-it-yourself version of department of motor vehicle processing; DealerTrack RegUSA for cross-border vehicle transactions; DealerTrack Electronic Lien & Title (ELT) to manage ELT; DealerTrack?s Title and Collateral Administration, a title management solution; and DealerTrack eDocs to digitize contracts and submit them electronically. Additionally, it provides data services; and on-demand credit application and contract processing services to indirect automotive finance industry in Canada. The company serves dealers, lenders, original equipment manufacturers, third party retailers, agents, and aftermarket providers. DealerTrack Holdings, Inc. was founded in 2001 and is headquartered in Lak e Success, New York.
Advisors' Opinion:- [By Patricio Kehoe]
The firm is currently Zacks Rank # 3 - Hold, and it also has a longer-term recommendation of ��utperfom�� For investors looking for a Zacks Rank # 1 ��Strong Buy, Dealertrack Technologies Inc (TRAK), Open Text Corporation (OTEX), Pegasystems Inc. (PEGA) Solera Holdings (SLH) or Ultimate Software Group Inc. (ULTI) could be the options.
No comments:
Post a Comment